IRIS
Evangelista, Laura
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.679
AS - Asia 7.415
SA - Sud America 1.445
EU - Europa 1.193
Continente sconosciuto - Info sul continente non disponibili 448
AF - Africa 151
OC - Oceania 22
Totale 19.353
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.416
SG - Singapore 5.062
BR - Brasile 1.190
CN - Cina 1.000
VN - Vietnam 653
IT - Italia 368
DE - Germania 347
HK - Hong Kong 152
CA - Canada 120
IN - India 110
GB - Regno Unito 91
AR - Argentina 89
BD - Bangladesh 81
MX - Messico 69
RU - Federazione Russa 50
EC - Ecuador 49
IQ - Iraq 46
ZA - Sudafrica 44
FR - Francia 39
TR - Turchia 39
PL - Polonia 38
NL - Olanda 33
CO - Colombia 30
ES - Italia 29
UA - Ucraina 27
VE - Venezuela 27
ID - Indonesia 26
MA - Marocco 25
PH - Filippine 24
SA - Arabia Saudita 24
AT - Austria 22
AE - Emirati Arabi Uniti 19
IE - Irlanda 19
SE - Svezia 19
JP - Giappone 18
PK - Pakistan 18
CL - Cile 17
CZ - Repubblica Ceca 17
FI - Finlandia 17
KE - Kenya 17
AU - Australia 13
AZ - Azerbaigian 13
HN - Honduras 13
IL - Israele 13
UZ - Uzbekistan 13
AL - Albania 12
MY - Malesia 12
PE - Perù 12
PY - Paraguay 12
TN - Tunisia 12
BO - Bolivia 11
EG - Egitto 11
GT - Guatemala 11
NG - Nigeria 11
NP - Nepal 11
LT - Lituania 10
CR - Costa Rica 9
DZ - Algeria 9
JM - Giamaica 9
JO - Giordania 8
OM - Oman 8
KG - Kirghizistan 7
TT - Trinidad e Tobago 7
DO - Repubblica Dominicana 6
KW - Kuwait 6
KZ - Kazakistan 6
LV - Lettonia 6
PT - Portogallo 6
TW - Taiwan 6
UY - Uruguay 6
GR - Grecia 5
IR - Iran 5
NI - Nicaragua 5
SY - Repubblica araba siriana 5
BE - Belgio 4
DK - Danimarca 4
ET - Etiopia 4
GA - Gabon 4
KR - Corea 4
NZ - Nuova Zelanda 4
SN - Senegal 4
AM - Armenia 3
BA - Bosnia-Erzegovina 3
BG - Bulgaria 3
BW - Botswana 3
BY - Bielorussia 3
EE - Estonia 3
GE - Georgia 3
KH - Cambogia 3
LB - Libano 3
NO - Norvegia 3
NR - Nauru 3
PS - Palestinian Territory 3
RO - Romania 3
SK - Slovacchia (Repubblica Slovacca) 3
SV - El Salvador 3
XK - ???statistics.table.value.countryCode.XK??? 3
BB - Barbados 2
BH - Bahrain 2
BS - Bahamas 2
Totale 18.872
Salva come PNG Salva come JPEG
Città #
Singapore 2.125
San Jose 1.509
Ashburn 1.169
Dallas 910
The Dalles 822
Council Bluffs 491
Shanghai 415
Beijing 226
Falkenstein 224
Ho Chi Minh City 215
Hanoi 144
Santa Clara 142
Hong Kong 140
Los Angeles 133
Milan 114
São Paulo 111
New York 96
Phoenix 86
Seattle 79
Rome 56
Brooklyn 48
Boardman 42
Atlanta 41
Chicago 38
Buffalo 36
Da Nang 36
Montreal 36
Wilmington 32
Warsaw 31
Assago 30
Chandler 30
Chennai 29
Haiphong 29
Orem 29
Houston 28
Boston 27
Curitiba 27
Munich 27
Rio de Janeiro 27
Toronto 26
Brasília 25
Belo Horizonte 21
Denver 21
Guayaquil 21
Charlotte 20
Dhaka 20
Johannesburg 20
Mexico City 20
Abbeville 19
Philadelphia 19
Dublin 18
Baghdad 17
Campinas 17
Goiânia 17
Stockholm 17
The Bronx 17
Figino 16
Helsinki 16
Princeton 16
Quito 16
Buenos Aires 15
Tokyo 15
Queens 14
San Diego 14
San Francisco 14
San Mateo 14
Amsterdam 13
Ann Arbor 13
Frankfurt am Main 13
London 13
Nairobi 13
Naples 13
Baku 12
Biên Hòa 12
Porto Alegre 12
Salvador 12
Bắc Ninh 11
Cape Town 11
Columbus 11
Guarulhos 11
Manila 11
Milwaukee 11
Ribeirão Preto 11
Ankara 10
Brno 10
Dubai 10
Düsseldorf 10
Fortaleza 10
Hangzhou 10
Indianapolis 10
Istanbul 10
Jacksonville 10
Las Vegas 10
Minneapolis 10
New Delhi 10
Reston 10
Santo André 10
Tashkent 10
Vienna 10
Washington 10
Totale 10.688
Salva come PNG Salva come JPEG
Nome #
10-Year Clinical Experience with 18F-Choline PET/CT: An Italian Multicenter Retrospective Assessment of 3343 Patients 638
PET-CT radiomics for immunotherapy response 186
18F-fluorodeoxyglucose PET/computed tomography and risk stratification after neoadjuvant treatment in esophageal cancer patients 142
BNCT treatment: 18F-FBPA PET-CT 117
A prospective trial for the evaluation of esophageal cancer patients: FDG PET/CT vs. c.e.CT vs. FDG PET/c.e.CT 107
Advantages of SiPM-based digital PET/CT technology in nuclear medicine clinical practice: a systematic review—Part 1 oncological setting 94
Detection rate of 18F-Choline positron emission tomography/computed tomography in patients with non-metastatic hormone sensitive and castrate resistant prostate cancer 94
Development and evaluation of a bayesian optimization FDG population-based input function for implementing parametric imaging in the clinical practice 91
Non-palpable Pulmonary Nodules and Uniportal-VATS: Radio-guided Localization (ROLL) Experience of a Lung Multidisciplinary Team 91
18F-FET PET/CT in Calcifying Pseudoneoplasm of the Neuraxis: First Case 90
New target therapies in prostate cancer: from radioligand therapy, to PARP-inhibitors and immunotherapy 86
SEGMENTAL FDG-PET/CT IN SOLITARY PULMONARY NODULE: PRELIMINARY DATA OF THE PET ITALIAN TRIAL 86
An incidental pancreatic finding at 18F-choline PET/CT: Chronic mass-forming pancreatitis 85
Emerging Radiopharmaceuticals in Pet Imaging for Mesothelioma: A Review of [18F]FDG Alternatives 83
18F-FDG PET/CT and urothelial carcinoma: Impact on management and prognosis—a multicenter retrospective study 83
An Evaluation of the Diagnostic Accuracy of [68Ga]Ga-PSMA-11 vs. [18F]F-PSMA-1007 PET/CT for Lymph Node Staging in Patient Candidates for Radical Prostatectomy and Lymph Node Dissection: A Single Institutional Analysis 82
Summary: SNMMI Procedure Standard/EANM Practice Guideline for Estrogen Receptor Imaging of Patients with Breast Cancer Using 16α-[18F]Fluoro-17β-Estradiol PET 80
State of the art of 18F-FDG PET/CT application in inflammation and infection: a guide for image acquisition and interpretation 74
Diagnostic and prognostic value of gated myocardial perfusion single-photon emission computed tomography in low-risk patients with left bundle-branch block 73
18F-choline PET/CT and PET/MRI in primary and recurrent hyperparathyroidism: a systematic review of the literature 73
Comparison between conventional imaging (CI) and wholebody 18F-choline (FCH) positron emission tomography/ computed tomography (PET/CT) in patients (pts) with prostate cancer (PCa) 72
Advancing Prostate Cancer Care: Prostate-specific Membrane Antigen–based Radioligand Therapy at the Forefront 71
PET/MR in recurrent glioblastoma patients treated with regorafenib: [18F]FET and DWI-ADC for response assessment and survival prediction 70
18F-DOPA and 18F-FDG PET/CT, scintigraphic localization and radioguided surgery of recurrent medullary thyroid cancer: two case reports 69
Prevalence of interstitial pneumonia suggestive of COVID-19 at 18F-FDG PET/CT in oncological asymptomatic patients in a high prevalence country during pandemic period: a national multi-centric retrospective study 69
18F-FDG PET-Derived Volume-Based Parameters to Predict Disease-Free Survival in Patients with Grade III Breast Cancer of Different Molecular Subtypes Candidates to Neoadjuvant Chemotherapy 68
18F-FDG PET/CT in non-small-cell lung cancer patients: a potential predictive biomarker of response to immunotherapy 67
18F-Facbc in Prostate Cancer: A Systematic Review and Meta-Analysis 67
Prostate MRI and PSMA-PET in the Primary Diagnosis of Prostate Cancer 67
The role of 18f-fdg pet/ct in staging and prognostication of mantle cell lymphoma: An italian multicentric study 65
18F-Fluoroestradiol Positron Emission Tomography In Breast Cancer Patients: Systematic Review Of The Literature &; Meta-Analysis 64
18F-choline PET/CT in prostate cancer for the staging, the restaging and planning radiotherapy treatment 64
Radiomics and theranostics with molecular and metabolic probes in prostate cancer: toward a personalized approach 64
An international expert opinion statement on the utility of PET/MR for imaging of skeletal metastases 64
MUNES: a MUltidisciplinar Neutron Source for BNCT and Nuclear Waste characterization 64
18F-Choline PET/CT: An Alternative Tracer for Hodgkin Lymphoma? 63
Advantages of SiPM-based digital PET/CT technology in nuclear medicine clinical practice: a systematic review– part 2 62
Relazione tra ischemia miocardica inducibile e livelli plasmatici di proteina C reattiva in pazienti con sospetta cardiopatia ischemica 62
L’imaging funzionale nelle disautonomie 61
18F-Choline PET/CT and prostatic gland/fossae recurrence: what can help to identify the local recurrence of disease? 61
18 F-Choline PET/CT in Leptomeningeal Breast Cancer Metastases 60
18F-FDG or 68Ga/18F-PSMA PET/CT in recurrent renal cancer? 60
Positron emission tomography/computed tomography and esophageal cancer in the clinical practice: How does it affect the prognosis? 60
ENDOCRINE ORGANS INVOLVEMENT IN BREAST CANCER: WHEN THE TEAMWORK MAKES THE DIFFERENCE 60
Diagnosi e stadiazione del cancro della mammella Il Medico Nucleare: stato dell’arte e risposta ai punti controversi 59
18F-FDG PET/MRI in adult sarcomas 59
Tumour markers and FDG PET/CT for prediction of disease relapse in patients with breast cancer 59
18F-DOPA PET/CT in different neuroendocrine settings: staging, restaging and increase in tumor markers 59
[18F]FDG and Lymphomas: Still a Winning Golden Couple in the Era of FAPI-Based Radiotracers 58
Copper, PeT/cT and prostate cancer: A systematic review of the literature 58
18F-Choline: Prostate Cancer18F-choline PET/CT: an increasing role in cancer evaluation 58
PET Radiomics and Response to Immunotherapy in Lung Cancer: A Systematic Review of the Literature 57
18F-FDG PET/CT in gynecologic malignancies: single Institution experience 57
Clinical Application of PET/MRI 57
The evolution of PET imaging in renal, bladder, upper urinary tract urothelial, testicular and penile carcinoma – Today’s impact, tomorrow’s potential 57
Comparison of prognostic value of baseline and nitrate Single-photon Emission computed tomography imaging in patients with ischaemic left ventricular dysfunction 57
The ability of 18F-choline PET/CT to identify local recurrence of prostate cancer 56
Head-to-Head Comparison between Peptide-Based Radiopharmaceutical for PET and SPECT in the Evaluation of Neuroendocrine Tumors: A Systematic Review 56
Clinical Impact of 18F-FDG PET/CT in the Diagnostic Workup of Pancreatic Ductal Adenocarcinoma: A Systematic Review 56
Diagnostic and prognostic impact of fluorine-18-fluorodeoxyglucose PET/CT in preoperative and postoperative setting of breast cancer patients 56
Additional value of PET and CT image-based features in the detection of occult lymph node metastasis in lung cancer: a systematic review from the literature 56
Prognostic and diagnostic value of [18F]FDG-PET/CT in restaging patients with small cell lung carcinoma: an Italian multicenter study 56
Additional value of pet radiomic features for the initial staging of prostate cancer: A systematic review from the literature 54
Somatostatin Receptor PET/CT Imaging for the Detection and Staging of Pancreatic NET: A Systematic Review and Meta-Analysis 54
An incidental finding behind adrenal incidentaloma 54
Lutathera® Orphans: State of the Art and Future Application of Radioligand Therapy with 177Lu-DOTATATE 53
Additional Value of PET and CT Image-Based Features in the Detection of Occult Lymph Node Metastases in Lung Cancer: A Systematic Review of the Literature 53
Head-to-head comparison between 18F-FDG PET/CT and PET/MRI in breast cancer 53
Ga-68 DOTA-peptides and F-18 FDG PET/CT in patients with neuroendocrine tumor: A review 53
18F-Fluoroestradiol positron emission tomography in breast cancer patients: systematic review of the literature & meta-analysis 53
[18F]FDG PET/CT and PET/MR in Patients with Adrenal Lymphoma: A Systematic Review of Literature and a Collection of Cases 53
18F-FDG PET/CT in ovarian cancer 53
Lymphoid organs’ metabolism and its role in predicting the outcomes of patients with malignant melanoma treated with immunotherapy: an exploratory study 53
PET-guided prognosis: a promising role of metabolic imaging in esophageal cancer. 52
Comparison between18F-Dopa and 18F-Fet PET/CT in patients with suspicious recurrent high grade glioma: A literature review and our experience 52
From Bottleneck to Enabler: A New Approach to Regulating Data-Driven Medical Research 52
Prognostic value of myocardial perfusion scintigraphy in elderly patients with hypertension: a 10-year follow-up analysis 52
Il radiologo e il medico nucleare: nodulo/i polmonare/i 51
An Incidental Uptake of 18F-Choline at PET/CT in Gastric Neuroendocrine Tumor 51
Molecular imaging of PARP in cancer: state-of-the-art 51
The Overall Survival and Progression-Free Survival in Patients with Advanced Adrenocortical Cancer Is Increased after the Multidisciplinary Team Evaluation 51
Comparison of MRI, PET, and 18F-choline PET/MRI in patients with oligometastatic recurrent prostate cancer 51
Indeterminate pulmonary nodules on CT images in breast cancer patient: The additional value of 18F-FDG PET/CT 51
The effects of androgen deprivation therapy on the 18F-choline uptake in prostate cancer patients undergoing neoadjuvant treatment 51
Ruolo della Tomografia ad emissione di fotone singolo nella definizione della probabilità di cardiopatia ischemica nei pazienti diabetici: risultati di un trial multi prospettico, multicentrico 50
Role of molecular imaging in the management of patients affected by inflammatory bowel disease: State-of-the-art 50
Incidental Detection of Sarcomatoid Lung Cancer by [18F] Choline Positron Emission Tomography/Computed Tomography 50
PET/CT And The Response To Immunotherapy In Lung Cancer 50
FDG PET/CT Volume-Based Quantitative Data and Survival Analysis in Breast Cancer Patients: A Systematic Review of the Literature 50
Relation between stress-induced myocardial ischemia and C- reactive protein levels in patients with suspected coronary arteery disease 50
Usefullness of stress cardiac single photon emission computesd tomography iomaging late after percutaneous coronary intervention for assessing cardiac events and time to such events 49
Choline PET or PET/CT and biochemical relapse of prostate cancer: a systematic review and meta-analysis 49
Boron neutron capture therapy and 18F-labelled borophenylalanine positron emission tomography: a critical and clinical overview of the literature 49
Interpretative reproducibility of cardiac stress imaging: direct comparison between dobutamine echocardiography and single photon emission computed tomography 49
What are the best ways to reduce the false-positive rate of 18F-FDG PET/CT in patients with breast cancer? 48
Therapeutic impact of (18)F-FDG PET/CT in recurrent differentiated thyroid carcinoma 48
Metastasi ossee: scintigrafia ossea e PET 48
Ruolo della PET/scintigrafia ossea? 48
Correction to: Predictive and prognostic value of 18F-DOPA PET/CT in patients affected by recurrent medullary carcinoma of the thyroid (Annals of Nuclear Medicine, (2018), 32, 1, (7-15), 10.1007/s12149-017-1213-0) 48
Can Baseline [18F]FDG PET/CT Predict Response to Immunotherapy After 6 Months and Overall Survival in Patients with Lung Cancer or Malignant Melanoma? A Multicenter Retrospective Study 48
Totale 6.975
Salva come PNG Salva come JPEG
Categoria #
all - tutte 110.648
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 110.648
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202227 0 0 0 8 1 2 1 1 4 2 6 2
2022/202375 12 5 8 12 3 5 0 3 14 5 8 0
2023/20241.081 2 5 9 4 1 10 3 4 357 59 272 355
2024/20254.266 114 153 19 74 52 500 216 204 846 1.102 475 511
2025/202610.757 1.579 671 862 808 411 603 3.346 665 464 639 280 429
2026/20273.090 330 591 1.744 425 0 0 0 0 0 0 0 0
Totale 19.353